Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma: A Literature Review and Treatment Perspectives

Advanced hepatocellular carcinoma is a prevalent and potentially aggressive disease. For more than a decade, treatment with sorafenib has been the only approved therapeutic approach. Moreover, no agent has been proven to prolong survival following the progression of disease after sorafenib treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Girardi, Daniel M., Pacífico, Jana Priscila M., Guedes de Amorim, Fernanda P. L., dos Santos Fernandes, Gustavo, Teixeira, Marcela C., Pereira, Allan A. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824026/
https://www.ncbi.nlm.nih.gov/pubmed/33396181
http://dx.doi.org/10.3390/ph14010028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824026/
https://www.ncbi.nlm.nih.gov/pubmed/33396181
http://dx.doi.org/10.3390/ph14010028

Ejemplares similares